• September 2022, Alcon acquired Ivantis, developer of the novel Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery. With this acquisition, the immediate integration of Ivantis associates helps ensure the continuity of the business and relationships with existing customers. It also allows Alcon to begin its future growth plans to bring Hydrus Microstent to more international markets and prioritize its ongoing evidence-based research.

• October 2022, Halma acquired IZI Medical Product for EUR 138 million (USD 145 million) to increase its presence across a range of diagnostic and therapeutic procedures.

In this report, the Ophthalmic Ultrasound Systems Market has been segmented by Product, Modality, End user and Geography.

Ophthalmic Ultrasound Systems Market, Segmentation by Product

The Ophthalmic Ultrasound Systems Market has been segmented by Product into A-Scan, B-Scan, Combined Scan, Pachymeter and Ultrasound Bio Microscope (UBM).

A-Scan

This segment holds a significant share of approximately 25-30%, primarily used for axial length measurement in cataract surgery planning. A-Scan systems are vital for calculating intraocular lens (IOL) power and remain widely adopted due to their accuracy, simplicity, and affordability in both clinical and surgical settings.

B-Scan

Contributing around 20-25% of the market, B-Scan systems provide detailed imaging of the posterior segment of the eye. They are essential for diagnosing conditions like retinal detachment, vitreous hemorrhage, and ocular tumors, especially in cases where the optical media is opaque.

Combined Scan

This segment, which includes integrated A-Scan and B-Scan systems, accounts for approximately 15-20% of the market. These dual-mode devices enhance workflow efficiency by providing both biometric measurement and detailed anatomical imaging in one unit, making them ideal for comprehensive ophthalmic evaluations.

Pachymeter

Holding a market share of about 10-15%, pachymeters are specialized for measuring corneal thickness, crucial for refractive surgery, glaucoma risk assessment, and keratoconus detection. Their portability and non-invasive nature have contributed to steady adoption in both clinics and pre-op screening centers.

Ultrasound Bio Microscope (UBM)

This advanced segment contributes roughly 10-12% of the market, offering high-resolution imaging of the anterior segment, including the ciliary body, iris, and anterior chamber angle. UBM is highly valuable in diagnosing angle-closure glaucoma, tumors, and evaluating intraocular structures pre- and post-surgery.

Ophthalmic Ultrasound Systems Market, Segmentation by Modality

The Ophthalmic Ultrasound Systems Market has been segmented by Modality into Portable and Standalone.

Portable

This segment accounts for approximately 55-60% of the market, driven by the growing demand for mobility, point-of-care diagnostics, and flexibility in clinical settings. Portable ophthalmic ultrasound systems are particularly valuable in outpatient clinics, rural healthcare centers, and mobile eye screening programs. Technological advances in wireless connectivity and handheld device integration are enhancing adoption.

Standalone

Contributing around 40-45% of the market, standalone systems are preferred in hospitals and advanced ophthalmology centers for comprehensive diagnostic imaging and pre-surgical planning. These systems offer superior imaging quality, large display interfaces, and advanced software capabilities, making them essential for complex ocular assessments.

Ophthalmic Ultrasound Systems Market, Segmentation by End user

The Ophthalmic Ultrasound Systems Market has been segmented by End user into Hospitals, Eye Research Institutes, and Ambulatory Surgical Centers.

Hospitals

This segment holds the largest market share of approximately 45-50%, driven by the high volume of ophthalmic diagnostics and pre-surgical evaluations conducted in hospital settings. Hospitals are equipped with both portable and standalone ultrasound systems, supporting comprehensive eye care services across multi-specialty departments.

Eye Research Institutes

Accounting for about 25-30% of the market, this segment includes institutions focused on ophthalmic disease research, clinical trials, and innovative device development. These centers rely on high-resolution imaging and advanced ultrasound modalities such as UBM for detailed ocular studies and experimental treatments.

Ambulatory Surgical Centers

Contributing nearly 20-25% of the market, these centers use ophthalmic ultrasound systems for pre-operative diagnostics and post-surgical follow-ups. The growing trend toward day-care eye procedures and demand for cost-effective, portable solutions make ultrasound imaging a key diagnostic tool in these outpatient facilities.

Ophthalmic Ultrasound Systems Market, Segmentation by Geography

In this report, the Ophthalmic Ultrasound Systems Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

Ophthalmic Ultrasound Systems Market Share (%), by Geographical Region

North America

This region leads the global market with a share of approximately 35-40%, driven by a strong presence of advanced healthcare facilities, early adoption of diagnostic imaging technologies, and a growing number of ophthalmic surgeries. The U.S. remains the largest contributor due to high R&D investment and the presence of key industry players.

Europe

Europe holds a significant share of around 25-30%, supported by robust public healthcare systems, growing awareness of early eye disease detection, and strong demand for advanced ophthalmic imaging equipment. Countries such as Germany, the UK, and France are leading the region in equipment modernization and clinical adoption.

Asia Pacific

This region is the fastest-growing market, accounting for nearly 20-25%, fueled by a large patient population, increasing cases of cataracts and glaucoma, and rising healthcare investments. Countries like China, India, and Japan are expanding access to portable diagnostic devices and building out ophthalmic infrastructure in both urban and rural areas.

Middle East & Africa

Representing about 5-7% of the global market, this region is seeing steady growth due to expanding specialty eye care centers in the Gulf countries and increased government health initiatives. However, limited access to advanced diagnostic tools in several African countries presents a barrier to wider adoption.

Latin America

Latin America accounts for approximately 5-8% of the market, led by countries such as Brazil, Mexico, and Argentina. Growth is supported by improvements in public health programs, rising demand for early ocular diagnosis, and increasing adoption of portable ultrasound systems in both urban hospitals and regional clinics.